DE60015127D1 - Inaktivierter impfstoff gegen katzen calicivirus - Google Patents

Inaktivierter impfstoff gegen katzen calicivirus

Info

Publication number
DE60015127D1
DE60015127D1 DE60015127T DE60015127T DE60015127D1 DE 60015127 D1 DE60015127 D1 DE 60015127D1 DE 60015127 T DE60015127 T DE 60015127T DE 60015127 T DE60015127 T DE 60015127T DE 60015127 D1 DE60015127 D1 DE 60015127D1
Authority
DE
Germany
Prior art keywords
cats
disabled
vaccine against
against calicivirus
calicivirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60015127T
Other languages
English (en)
Other versions
DE60015127T2 (de
Inventor
Herve Poulet
Gabriel Goutebroze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9909420A external-priority patent/FR2796281B1/fr
Application filed by Merial SAS filed Critical Merial SAS
Publication of DE60015127D1 publication Critical patent/DE60015127D1/de
Application granted granted Critical
Publication of DE60015127T2 publication Critical patent/DE60015127T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009—Picornaviridae, e.g. hepatitis A virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C12N2770/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60015127T 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus Expired - Lifetime DE60015127T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9909420 1999-07-16
FR9909420A FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline
FR0001759 2000-02-11
FR0001759A FR2796282B1 (fr) 1999-07-16 2000-02-11 Vaccin inactive contre la calicivirose feline
PCT/FR2000/002050 WO2001005835A1 (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline

Publications (2)

Publication Number Publication Date
DE60015127D1 true DE60015127D1 (de) 2004-11-25
DE60015127T2 DE60015127T2 (de) 2005-10-13

Family

ID=26212168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015127T Expired - Lifetime DE60015127T2 (de) 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus

Country Status (17)

Country Link
EP (1) EP1194450B1 (de)
JP (1) JP4841775B2 (de)
KR (3) KR20080012405A (de)
AR (1) AR024770A1 (de)
AT (1) ATE280182T1 (de)
AU (1) AU6576400A (de)
BR (1) BR0012500B1 (de)
CA (1) CA2378802C (de)
DE (1) DE60015127T2 (de)
DK (1) DK1194450T3 (de)
ES (1) ES2231233T3 (de)
FR (1) FR2796282B1 (de)
HU (1) HU228430B1 (de)
MX (1) MXPA02000536A (de)
PL (1) PL205298B1 (de)
PT (1) PT1194450E (de)
WO (1) WO2001005835A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
ATE526034T1 (de) * 2004-01-21 2011-10-15 Merial Ltd Verbesserte inaktivierte fcv-vakzinen
MX2008001326A (es) * 2005-07-28 2008-03-19 Pfizer Prod Inc Procedimientos de administracion de vacunas, nuevos calicivirus felinos, y tratamientos para inmunizar animales contra paraovirus felino y herpes virus felino.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055598C (en) * 1989-07-21 1998-12-08 Richard C. Wardley Feline calicivirus gene
JP3514482B2 (ja) * 1992-02-28 2004-03-31 財団法人化学及血清療法研究所 抗ネコカリシウイルス組換え抗体および該抗体からなる治療剤
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same

Also Published As

Publication number Publication date
ES2231233T3 (es) 2005-05-16
MXPA02000536A (es) 2002-07-30
BR0012500A (pt) 2002-04-02
HU228430B1 (en) 2013-03-28
AU6576400A (en) 2001-02-05
WO2001005835A1 (fr) 2001-01-25
EP1194450A1 (de) 2002-04-10
HUP0202389A3 (en) 2003-12-29
EP1194450B1 (de) 2004-10-20
HUP0202389A2 (hu) 2002-12-28
PL352461A1 (en) 2003-08-25
BR0012500B1 (pt) 2011-03-22
CA2378802C (en) 2012-01-24
AR024770A1 (es) 2002-10-23
KR100934687B1 (ko) 2009-12-31
CA2378802A1 (en) 2001-01-25
KR20080012405A (ko) 2008-02-11
JP2003505400A (ja) 2003-02-12
PL205298B1 (pl) 2010-04-30
DK1194450T3 (da) 2005-02-21
KR20020020785A (ko) 2002-03-15
KR20090007803A (ko) 2009-01-20
DE60015127T2 (de) 2005-10-13
FR2796282A1 (fr) 2001-01-19
PT1194450E (pt) 2005-03-31
KR100859824B1 (ko) 2008-09-23
JP4841775B2 (ja) 2011-12-21
FR2796282B1 (fr) 2001-10-26
ATE280182T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
ATE312624T1 (de) Impfstoff gegen hpv
NO20014322D0 (no) Vaksine
DE50002776D1 (de) Fungizide wirkstoffkombinationen
DE60111908D1 (de) Implantierbares medizinisches Gerät
DE60037767D1 (de) Medizinische laserfeste Fassvorrichtung
NO20021433L (no) Vaksiner
NO20020235D0 (no) Medisinsk anordning
NO20043494L (no) Infeksjonsresistent medisinsk innretning
DE50111900D1 (de) Medizinisches implantat
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763D0 (no) Vaksine
ID26300A (id) Benda penyerap sekali pakai
DE50102752D1 (de) Fungizide wirkstoffkombinationen
DE60226218D1 (de) Impfstoff gegen pferdeherpesvirus
DE60005113D1 (de) Medizinischer Schlauch
DE50007895D1 (de) Fungizide wirkstoffkombinationen
DE60004451D1 (de) Isothiazolonkonzentrate
DE60015127D1 (de) Inaktivierter impfstoff gegen katzen calicivirus
PT1161148E (pt) Composicoes insecticidas sinergeticas
DE50002125D1 (de) Fungizide wirkstoffkombinationen
DE60005627D1 (de) Verbesserte medizinische spritzen
DE60334226D1 (de) Vakzine gegen infektiöse katzen-peritonitis
IS6184A (is) Bóluefni gegn ISA veiru
DE60017741D1 (de) Medizinisches implantat
ATE295687T1 (de) Gegen pflanzenkrankheiten verwendbare pseudomycine